Unraveling the Mechanisms of Inherited Predisposition to Childhood Leukemia |
Boston Children’s Hospital / Vijay Sankaran, MD/PhD |
Innovation Grants |
2024 |
Massachusetts |
Novel mechanisms and therapeutic targeting of chemoresistant rhabdomyosarcoma |
Massachusetts General Hospital / Yueyang Wang, PhD |
Young Investigator Grants |
2024 |
Massachusetts |
Illuminating Choroid Plexus Carcinoma Vascularization in Real Time |
Boston Children’s Hospital / Maria Lehtinen, PhD |
Innovation Grants |
2024 |
Massachusetts |
Gene-mediated cytotoxic immunotherapy in pediatric patients with recurrent malignant brain tumors |
University of Michigan / Andrea Franson, MD |
'A' Award Grants |
2024 |
Michigan |
Utilizing chromatin directed inhibitors to regulate gene expression in Ewing sarcoma for therapeutic benefit |
University of North Carolina / Justin Sperlazza, MD/PhD |
Young Investigator Grants |
2024 |
North Carolina |
Exploring the Interplay of Microbiome, Bile Acids, Immune Reconstitution, and Clinical Outcomes Following Allogeneic Hematopoietic Transplantation in Pediatrics |
Memorial Sloan-Kettering Cancer Center / Oriana Miltiadous, MD |
Reach Grants |
2024 |
New York |
Direct targeting of oncoprotein assembly using mimetic peptide interference |
Memorial Sloan-Kettering Cancer Center / Alex Kentsis, MD/PhD |
Innovation Grants |
2024 |
New York |
Targeting protein synthesis in pediatric acute myeloid leukemia |
Cincinnati Children's Hospital Medical Center / Courtney Jones, PhD |
'A' Award Grants |
2024 |
Ohio |
Vaccine-boosted CAR T cell therapy for high risk neuroblastoma |
Children’s Hospital of Philadelphia / Timothy Spear, MD/PhD |
Young Investigator Grants |
2024 |
Pennsylvania |
IGFBPL1 Peptide-Centric Chimeric Antigen Receptor Autologous T Cells for Relapsed HLA-A*02 Neuroblastoma and Medulloblastoma |
Children’s Hospital of Philadelphia / John Maris, MD |
Reach Grants |
2024 |
Pennsylvania |